Last 12 months
Inside the activity.
7 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 6 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2025 Filed Nov 4, 2025 14:58 UTC |
Jameson Jeremy AndrewEVP - Chief Credit Officer
|
GrantCommon Stock | 23,310 | $14.64 | $341,258.40 |
DisclosureSEC source: 0001466026-25-000064 · primary_01.xml · nonDerivative · entry 1 Jameson Jeremy Andrew · CIK 0002083171 · EVP - Chief Credit Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,984 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 14:39 UTC | GrantCommon Stock | 10,760 | $14.64 | $157,526.40 |
DisclosureSEC source: 0001466026-25-000061 · primary_01.xml · nonDerivative · entry 1 Casey Daniel Edward · CIK 0002015189 · CROF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,112 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
|
| November 03, 2025 Filed Nov 4, 2025 21:57 UTC |
Spring Donald J.Chief Accounting Officer
|
GrantCommon Stock | 4,000 | $14.64 | $58,560.00 |
DisclosureSEC source: 0001466026-25-000065 · primary_01.xml · nonDerivative · entry 3 Spring Donald J. · CIK 0001786773 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,386 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 14:37 UTC |
Ludwig Jeffrey G.Director · President & CEO
|
GrantCommon Stock | 38,410 | $14.64 | $562,322.40 |
DisclosureSEC source: 0001466026-25-000060 · primary_01.xml · nonDerivative · entry 1 Ludwig Jeffrey G. · CIK 0001526235 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,659.432 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 14:33 UTC |
Lemke EricChief Financial Officer
|
GrantCommon Stock | 14,940 | $14.64 | $218,721.60 |
DisclosureSEC source: 0001466026-25-000058 · primary_01.xml · nonDerivative · entry 3 Lemke Eric · CIK 0001794690 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,333 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 14:26 UTC |
Mefford Jeffrey S.President
|
GrantCommon Stock | 23,310 | $14.64 | $341,258.40 |
DisclosureSEC source: 0001466026-25-000056 · primary_01.xml · nonDerivative · entry 3 Mefford Jeffrey S. · CIK 0001526238 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,059.47 F1 · security: RSA with 4yr - 25% vesting schedule Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:57 UTC |
Spring Donald J.Chief Accounting Officer
|
Tax withholdingCommon Stock | 199 | $14.64 | $2,913.36 |
DisclosureSEC source: 0001466026-25-000065 · primary_01.xml · nonDerivative · entry 2 Spring Donald J. · CIK 0001786773 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,386 Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 14:33 UTC |
Lemke EricChief Financial Officer
|
Tax withholdingCommon Stock | 472 | $14.64 | $6,910.08 |
DisclosureSEC source: 0001466026-25-000058 · primary_01.xml · nonDerivative · entry 2 Lemke Eric · CIK 0001794690 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,393 Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 14:26 UTC |
Mefford Jeffrey S.President
|
Tax withholdingCommon Stock | 742 | $14.64 | $10,862.88 |
DisclosureSEC source: 0001466026-25-000056 · primary_01.xml · nonDerivative · entry 2 Mefford Jeffrey S. · CIK 0001526238 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,749.47 Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:57 UTC |
Spring Donald J.Chief Accounting Officer
|
Tax withholdingCommon Stock | 114 | $14.64 | $1,668.96 |
DisclosureSEC source: 0001466026-25-000065 · primary_01.xml · nonDerivative · entry 1 Spring Donald J. · CIK 0001786773 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,585 Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 14:33 UTC |
Lemke EricChief Financial Officer
|
Tax withholdingCommon Stock | 294 | $14.64 | $4,304.16 |
DisclosureSEC source: 0001466026-25-000058 · primary_01.xml · nonDerivative · entry 1 Lemke Eric · CIK 0001794690 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,865 Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 14:26 UTC |
Mefford Jeffrey S.President
|
Tax withholdingCommon Stock | 445 | $14.64 | $6,514.80 |
DisclosureSEC source: 0001466026-25-000056 · primary_01.xml · nonDerivative · entry 1 Mefford Jeffrey S. · CIK 0001526238 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,491.47 Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:34 UTC |
Franklin TravisDirector
|
GrantCommon Share Equivalent · Derivative | 141.079 | $17.35 Strike: $22.65 | $2,447.72 |
DisclosureSEC source: 0001466026-25-000049 · primary_01.xml · derivative · entry 2 Franklin Travis · CIK 0002021449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,490.321 Underlying: Common Stock · 141.079 shares Expires not disclosed F1 · security: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F4 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F1 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:34 UTC |
Franklin TravisDirector
|
GrantCommon Share Equivalent · Derivative | 700.117 | $17.14 Strike: $22.65 | $12,000.01 |
DisclosureSEC source: 0001466026-25-000049 · primary_01.xml · derivative · entry 1 Franklin Travis · CIK 0002021449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,349.242 Underlying: Common Stock · 700.117 shares Expires not disclosed F1 · security: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:31 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 472.6842 | $17.35 | $8,201.07 |
DisclosureSEC source: 0001466026-25-000047 · primary_01.xml · derivative · entry 4 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,316.9088 Underlying: Common Stock · 472.6842 shares Expires not disclosed F2 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:31 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 670.945 | $17.14 | $11,500.00 |
DisclosureSEC source: 0001466026-25-000047 · primary_01.xml · derivative · entry 3 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,844.2246 Underlying: Common Stock · 670.945 shares Expires not disclosed F2 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F2 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:25 UTC |
McDaniel Jerry L.Director
|
GrantCommon Share Equivalent · Derivative | 693.4525 | $17.35 | $12,031.40 |
DisclosureSEC source: 0001466026-25-000043 · primary_01.xml · derivative · entry 8 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,230.9313 Underlying: Common Stock · 693.4525 shares Expires not disclosed F3 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:32 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 899.0265 | $17.35 | $15,598.11 |
DisclosureSEC source: 0001466026-25-000048 · primary_01.xml · derivative · entry 4 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,652.1691 Underlying: Common Stock · 899.0265 shares Expires not disclosed F3 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:36 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 2,054.1579 | $17.35 | $35,639.64 |
DisclosureSEC source: 0001466026-25-000051 · primary_01.xml · derivative · entry 6 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,290.913 Underlying: Common Stock · 2,054.1579 shares Expires not disclosed F3 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F5 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:36 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 9.918 | $17.14 | $169.99 |
DisclosureSEC source: 0001466026-25-000051 · primary_01.xml · derivative · entry 5 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,236.7551 Underlying: Common Stock · 9.918 shares Expires not disclosed F3 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F3 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:35 UTC |
Smith Jeffrey C.Director
|
GrantCommon Share Equivalent · Derivative | 369.1182 | $17.35 | $6,404.20 |
DisclosureSEC source: 0001466026-25-000050 · primary_01.xml · derivative · entry 3 Smith Jeffrey C. · CIK 0001526326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,671.2482 Underlying: Common Stock · 369.1182 shares Expires not disclosed F1 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F1 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F1 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:35 UTC |
Smith Jeffrey C.Director
|
GrantCommon Share Equivalent · Derivative | 415.694 | $17.14 | $7,125.00 |
DisclosureSEC source: 0001466026-25-000050 · primary_01.xml · derivative · entry 2 Smith Jeffrey C. · CIK 0001526326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,302.13 Underlying: Common Stock · 415.694 shares Expires not disclosed F1 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F1 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:25 UTC |
DiMotta JenniferDirector
|
GrantCommon Share Equivalent · Derivative | 289.5654 | $17.35 | $5,023.96 |
DisclosureSEC source: 0001466026-25-000042 · primary_01.xml · derivative · entry 2 DiMotta Jennifer · CIK 0001757806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,651.6657 Underlying: Common Stock · 289.5654 shares Expires not disclosed F1 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F1 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F1 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:14 UTC |
Bingham Richard DeanDirector
|
GrantCommon Share Equivalent · Derivative | 918.903 | $17.14 | $15,750.00 |
DisclosureSEC source: 0001466026-25-000041 · primary_01.xml · derivative · entry 6 Bingham Richard Dean · CIK 0001832547 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,933.9363 Underlying: Common stock · 918.903 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F4 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F2 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 00:14 UTC |
Bingham Richard DeanDirector
|
GrantCommon Share Equivalent · Derivative | 541.3798 | $17.35 | $9,392.94 |
DisclosureSEC source: 0001466026-25-000041 · primary_01.xml · derivative · entry 5 Bingham Richard Dean · CIK 0001832547 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,015.0333 Underlying: Common stock · 541.3798 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 16:49 UTC |
Carlson Gerald JosephDirector
|
GrantCommon Share Equivalent · Derivative | 158.4075 | $17.35 | $2,748.37 |
DisclosureSEC source: 0001466026-25-000052 · primary_01.xml · derivative · entry 3 Carlson Gerald Joseph · CIK 0002009794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,622.2225 Underlying: Common Stock · 158.4075 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 16:49 UTC |
Carlson Gerald JosephDirector
|
GrantCommon Share Equivalent · Derivative | 875.146 | $17.14 | $15,000.00 |
DisclosureSEC source: 0001466026-25-000052 · primary_01.xml · derivative · entry 2 Carlson Gerald Joseph · CIK 0002009794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,463.815 Underlying: Common Stock · 875.146 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F2 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| August 05, 2025 Filed Aug 11, 2025 17:06 UTC |
Spring Donald J.Chief Accounting Officer
|
Disposition to issuerCommon Stock | 53 | $16.71 | $885.63 |
DisclosureSEC source: 0001593968-25-000907 · primary_01.xml · nonDerivative · entry 1 Spring Donald J. · CIK 0001786773 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,699 Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:19 UTC |
Franklin TravisDirector
|
GrantCommon Share Equivalent · Derivative | 3,290.993 | $17.32 Strike: $22.65 | $57,000.00 |
DisclosureSEC source: 0001593968-25-000791 · primary_01.xml · derivative · entry 2 Franklin Travis · CIK 0002021449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,649.125 Underlying: Common Stock · 3,290.993 shares Expires not disclosed F1 · security: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F4 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:19 UTC |
Franklin TravisDirector
|
GrantCommon Share Equivalent · Derivative | 74.273 | $17.88 Strike: $22.65 | $1,328.00 |
DisclosureSEC source: 0001593968-25-000791 · primary_01.xml · derivative · entry 1 Franklin Travis · CIK 0002021449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,358.132 Underlying: Common Stock · 74.273 shares Expires not disclosed F1 · security: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F1 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 17:03 UTC |
Carlson Gerald JosephDirector
|
GrantCommon Share Equivalent · Derivative | 3,464.203 | $17.32 | $60,000.00 |
DisclosureSEC source: 0001593968-25-000807 · primary_01.xml · derivative · entry 2 Carlson Gerald Joseph · CIK 0002009794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,588.669 Underlying: Common Stock · 3,464.203 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F3 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 17:03 UTC |
Carlson Gerald JosephDirector
|
GrantCommon Share Equivalent · Derivative | 87.333 | $17.88 | $1,561.51 |
DisclosureSEC source: 0001593968-25-000807 · primary_01.xml · derivative · entry 1 Carlson Gerald Joseph · CIK 0002009794 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,124.466 Underlying: Common Stock · 87.333 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F2 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:30 UTC |
McDonnell Jeffrey MDirector
|
GrantRestricted Stock Unit · Derivative | 3,262.125 | $17.32 | $56,500.01 |
DisclosureSEC source: 0001593968-25-000795 · primary_01.xml · derivative · entry 4 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,455.125 Underlying: Common Stock · 3,262.125 shares Expires not disclosed F2 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F2 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:30 UTC |
McDonnell Jeffrey MDirector
|
GrantCommon Share Equivalents · Derivative | 381.172 | $17.88 | $6,815.36 |
DisclosureSEC source: 0001593968-25-000795 · primary_01.xml · derivative · entry 3 McDonnell Jeffrey M · CIK 0001672608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,173.2796 Underlying: Common Stock · 381.172 shares Expires not disclosed F2 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:42 UTC |
McDaniel Jerry L.Director
|
GrantCommon Share Equivalent · Derivative | 640.757 | $17.88 | $11,456.74 |
DisclosureSEC source: 0001593968-25-000802 · primary_01.xml · derivative · entry 8 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,537.4788 Underlying: Common Stock · 640.757 shares Expires not disclosed F3 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F3 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:42 UTC |
McDaniel Jerry L.Director
|
GrantCommon Stock | 2,598 | $17.32 | $44,997.36 |
DisclosureSEC source: 0001593968-25-000802 · primary_01.xml · nonDerivative · entry 1 McDaniel Jerry L. · CIK 0001671605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,258 F1 · acquired: Annual Director Stock Award with immediate vesting schedule. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:40 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 830.712 | $17.88 | $14,853.13 |
DisclosureSEC source: 0001593968-25-000800 · primary_01.xml · derivative · entry 4 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,753.1426 Underlying: Common Stock · 830.712 shares Expires not disclosed F4 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F5 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F4 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:40 UTC |
Ramos Richard TDirector
|
GrantCommon Stock | 2,598 | $17.32 | $44,997.36 |
DisclosureSEC source: 0001593968-25-000800 · primary_01.xml · nonDerivative · entry 1 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,103 F1 · acquired: Annual Director Stock Award with immediate vesting schedule. F2 · balance_after: Jointly owned with spouse. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:38 UTC |
Ramos Richard TDirector
|
GrantCommon Share Equivalent · Derivative | 830.712 | $17.88 | $14,853.13 |
DisclosureSEC source: 0001593968-25-000799 · primary_01.xml · derivative · entry 4 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,753.1426 Underlying: Common Stock · 830.712 shares Expires not disclosed F4 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F5 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F4 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:38 UTC |
Ramos Richard TDirector
|
GrantCommon Stock | 2,598 | $17.32 | $44,997.36 |
DisclosureSEC source: 0001593968-25-000799 · primary_01.xml · nonDerivative · entry 1 Ramos Richard T · CIK 0001671608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,103 F1 · acquired: Annual Director Stock Award with immediate vesting schedule. F2 · balance_after: Jointly owned with spouse. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 17:02 UTC |
Bingham Richard DeanDirector
|
GrantRestricted Stock Unit · Derivative | 3,507.506 | $17.32 | $60,750.00 |
DisclosureSEC source: 0001593968-25-000806 · primary_01.xml · derivative · entry 6 Bingham Richard Dean · CIK 0001832547 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,879.106 Underlying: Common Stock · 3,507.506 shares Expires not disclosed F4 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F5 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F4 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 17:02 UTC |
Bingham Richard DeanDirector
|
GrantCommon Share Equivalent · Derivative | 440.465 | $17.88 | $7,875.51 |
DisclosureSEC source: 0001593968-25-000806 · primary_01.xml · derivative · entry 5 Bingham Richard Dean · CIK 0001832547 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,473.6535 Underlying: Common stock · 440.465 shares Expires not disclosed F2 · derivative.exercise_price: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F2 · derivative.expiration_date: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:59 UTC |
DiMotta JenniferDirector
|
GrantCommon Share Equivalent · Derivative | 267.563 | $17.88 | $4,784.03 |
DisclosureSEC source: 0001593968-25-000805 · primary_01.xml · derivative · entry 2 DiMotta Jennifer · CIK 0001757806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,362.1003 Underlying: Common Stock · 267.563 shares Expires not disclosed F2 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F2 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:59 UTC |
DiMotta JenniferDirector
|
GrantCommon Stock | 2,598 | $17.32 | $44,997.36 |
DisclosureSEC source: 0001593968-25-000805 · primary_01.xml · nonDerivative · entry 1 DiMotta Jennifer · CIK 0001757806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,799 F1 · acquired: Annual Director Stock Award with immediate vesting schedule. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:43 UTC |
Ludwig Jeffrey G.Director · President & CEO
|
GrantCommon Stock | 1,615 | $15.48 | $25,000.20 |
DisclosureSEC source: 0001593968-25-000803 · primary_01.xml · nonDerivative · entry 1 Ludwig Jeffrey G. · CIK 0001526235 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,249.432 F1 · price: Represents shares acquired by the reporting person through contributions to the Employee Stock Purchase Plan of the Issuer (ESPP). for the calendar quarter. Pursuant to the ESPP, the price used for each quarterly purchase is the lower of 90% of the fair market of the Issuers shares on the first day of the calendar quarter or the closing price of the shares on the last day of the quarter. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:27 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 9.815 | $17.32 | $170.00 |
DisclosureSEC source: 0001593968-25-000794 · primary_01.xml · derivative · entry 6 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,226.8371 Underlying: Common Stock · 9.815 shares Expires not disclosed F4 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F6 · price: Represents common share equivalents held pursuant to Directors Deferred Compensation Plan as of the date of this form. Each common share equivalent is the economic equivalent of one share of common stock. Common stock equivalents become payable upon the reporting persons termination of service as a director. F4 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:27 UTC |
Schultz Robert F.Director
|
GrantCommon Share Equivalent · Derivative | 1,897.904 | $17.88 | $33,934.52 |
DisclosureSEC source: 0001593968-25-000794 · primary_01.xml · derivative · entry 5 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,217.0221 Underlying: Common Stock · 1,897.904 shares Expires not disclosed F4 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F5 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F4 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F4 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:27 UTC |
Schultz Robert F.Director
|
GrantCommon Stock | 2,598 | $17.32 | $44,997.36 |
DisclosureSEC source: 0001593968-25-000794 · primary_01.xml · nonDerivative · entry 1 Schultz Robert F. · CIK 0001526325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,715 F1 · acquired: Annual Director Stock Award with immediate vesting schedule. F2 · balance_after: Includes holdings through a self-directed IRA or revocable grantor trust Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:26 UTC |
Smith Jeffrey C.Director
|
GrantCommon Share Equivalent · Derivative | 289.78 | $17.88 | $5,181.27 |
DisclosureSEC source: 0001593968-25-000793 · primary_01.xml · derivative · entry 3 Smith Jeffrey C. · CIK 0001526326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,886.436 Underlying: Common Stock · 289.78 shares Expires not disclosed F1 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F3 · price: Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares. Common share equivalents received for dividend reinvestments fully vested on the transaction date listed above and become payable upon termination of service as a director. F1 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F1 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 16:26 UTC |
Smith Jeffrey C.Director
|
GrantRestricted Stock Unit · Derivative | 3,009.527 | $17.32 | $52,125.01 |
DisclosureSEC source: 0001593968-25-000793 · primary_01.xml · derivative · entry 2 Smith Jeffrey C. · CIK 0001526326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,126.306 Underlying: Common Stock · 3,009.527 shares Expires not disclosed F1 · derivative.exercise_price: Each common stock equivalent is the economic equivalent of one share of common stock. F2 · price: Represents restricted stock units acquired by the reporting person under the 2019 Long-term incentive plan and deferred under the DDCP as of the date of this form. Each restricted stock unit is the contingent right to receive one share of Issuer common stock. Vested shares will be delivered to the reporting person based on the terms of the DDCP and the reporting persons distribution elections thereunder. F1 · derivative.exercise_date: Each common stock equivalent is the economic equivalent of one share of common stock. F1 · derivative.expiration_date: Each common stock equivalent is the economic equivalent of one share of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.